Panoplia Laboratories is developing broad-spectrum antivirals in order to fight future pandemics, and we are looking to hire one researcher to be a part of our team.
Job description: Responsibilities would include:
Designing and cloning new antiviral candidates
Designing and executing in vitro assays to characterize antiviral candidates
Assisting with the design and execution of in vivo studies for the characterization of antiviral candidates
Analyzing data from in vitro and in vivo studies
Actively communicating results with the rest of the team
As an early member of our team, you would also have the ability to learn new skills, receive technical mentorship, and play a central role in our path to making an impact.
Salary/benefits: $75,000/year, medical/dental/vision insurance, unlimited paid time off
Location: Cambridge, MA
Suggested skills/attributes: We encourage everyone who is interested to apply! But some of the skills/attributes we are looking for include:
Mammalian cell culture experience
Experience working with viruses in vitro
Familiarity with general molecular biology techniques: flow cytometry, PCR, gel electrophoresis, qPCR, ELISAs
Experience working with mice
Working well with a team
Flexibility in taking on different tasks
Enthusiasm about working towards a shared mission
The application process: Please fill out the Google Form here – the application is on a rolling deadline. We will follow up with individual applicants by e-mail to conduct a short work test and schedule a 1-hour interview with Executive Director Brian Wang. Finally, we’ll invite you for a tour of the lab/office and for lunch with the rest of the team (in-person or virtually).
More about Panoplia Laboratories:We are a nonprofit organization conducting research on broad-spectrum antivirals until they are technically de-risked enough to be further developed through the clinic by biotech or pharmaceutical companies. Our current research program focuses on the development of inhalable, DNA-encoded broad-spectrum antiviral proteins we call “virus-targeting chimeras” (VIRTACs), inspired by the innate immune system. You can find even more information about us in a public funding proposal we put out last year here.
If you have any questions, please reach out to info@panoplialabs.org!
Panoplia Laboratories is developing broad-spectrum antivirals in order to fight future pandemics, and we are looking to hire one researcher to be a part of our team.
Job description: Responsibilities would include:
Designing and cloning new antiviral candidates
Designing and executing in vitro assays to characterize antiviral candidates
Assisting with the design and execution of in vivo studies for the characterization of antiviral candidates
Analyzing data from in vitro and in vivo studies
Actively communicating results with the rest of the team
As an early member of our team, you would also have the ability to learn new skills, receive technical mentorship, and play a central role in our path to making an impact.
Salary/benefits: $75,000/year, medical/dental/vision insurance, unlimited paid time off
Location: Cambridge, MA
Suggested skills/attributes: We encourage everyone who is interested to apply! But some of the skills/attributes we are looking for include:
Mammalian cell culture experience
Experience working with viruses in vitro
Familiarity with general molecular biology techniques: flow cytometry, PCR, gel electrophoresis, qPCR, ELISAs
Experience working with mice
Working well with a team
Flexibility in taking on different tasks
Enthusiasm about working towards a shared mission
The application process: Please fill out the Google Form here – the application is on a rolling deadline. We will follow up with individual applicants by e-mail to conduct a short work test and schedule a 1-hour interview with Executive Director Brian Wang. Finally, we’ll invite you for a tour of the lab/office and for lunch with the rest of the team (in-person or virtually).
More about Panoplia Laboratories: We are a nonprofit organization conducting research on broad-spectrum antivirals until they are technically de-risked enough to be further developed through the clinic by biotech or pharmaceutical companies. Our current research program focuses on the development of inhalable, DNA-encoded broad-spectrum antiviral proteins we call “virus-targeting chimeras” (VIRTACs), inspired by the innate immune system. You can find even more information about us in a public funding proposal we put out last year here.
If you have any questions, please reach out to info@panoplialabs.org!
Exciting!!! Wish I could come back and join you guys :)
We miss you!